Cytek Biosciences, Inc.‘s stocks are currently a part of 78 hedge funds’ portfolios, which represents 43.52% of the total amount of its stocks outstanding. This makes up a total of 58.49M shares of Cytek Biosciences, Inc.. Compared to the previous quarter, the number grew by 10.54% or 5.57M shares more. As for the holding position changes, 42.31% (33) of current hedge fund investors increased the number of shares held, 23.08% (18) of current holders sold a part of the shares held, and 12.82% (10) closed the holdings completely. 13 hedge funds are new holders of Cytek Biosciences, Inc. stock in Q3 2022, it is 16.67% of total holders.